Stockscreener 앱 받기
3.71
0.27%
0.010
전일 마감가:
$3.70
열려 있는:
$3.7
하루 거래량:
23,220
Relative Volume:
0.03
시가총액:
$4.98M
수익:
-
순이익/손실:
$-11.00M
주가수익비율:
-9.3782
EPS:
-0.3956
순현금흐름:
$-11.99M
1주 성능:
-12.29%
1개월 성능:
-37.23%
6개월 성능:
-69.96%
1년 성능:
-97.38%
1일 변동 폭
$3.65
$3.82
1주일 범위
$3.42
$4.26
52주 변동 폭
$3.42
$145.00
Liminatus Pharma Inc Stock (LIMN) Company Profile
명칭
Liminatus Pharma Inc
전화
213-273-5453
주소
12611 HIDDENCREEK WAY, CERRITOS
Compare LIMN vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
3.71 | 151.25K | 0 | -11.00M | -11.99M | -0.3956 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Press Releases about Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) - FinancialContent
17,272,739 Common Stock of Liminatus Pharma, Inc. are subject to a Lock-Up Agreement Ending on 19-AUG-2026. - marketscreener.com
Liminatus Pharma to implement 1-for-50 reverse stock split - Investing.com
Liminatus Pharma Enacts Reverse Split to Maintain Listing - TipRanks
Liminatus Pharma announces 1-for-50 reverse stock split - TipRanks
Liminatus Pharma Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Liminatus Pharma to implement 1-for-50 reverse stock split By Investing.com - Investing.com UK
Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock - The Manila Times
Liminatus Pharma, Inc. Announces Reverse Stock Split of Its Common Stock - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Liminatus Pharma (LIMN) Stock Analysis Report | Financials & Insights - Benzinga France
Liminatus Pharma Warrants (LIMNW) Tumble 13.79% to $0.05 as Key Level Comes Into FocusScalping Stock Signals - vinanet.vn
Liminatus Pharma (LIMN) Slides 6.6% to $0.14, Testing Critical $0.13 SupportLow Vol ETF - vinanet.vn
Liminatus Pharma, Inc. Q2 2026: Net income $(1.41)M, EPS $(0.03) — 10-Q Summary - TradingView
Liminatus Pharma (LIMN) logs $2.5M loss and fights Nasdaq listing threats - Stock Titan
Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update - TipRanks
These stocks are the most active in today's session - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Liminatus Pharma moves to Nasdaq Capital Market By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma moves to Nasdaq Capital Market - Investing.com
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement - The Manila Times
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Bid Price Compliance - Quiver Quantitative
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance ... - Herald and News
Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance With Minimum Bid Price Requirement - Moomoo
Liminatus Pharma moves Nasdaq listing to Capital Market tier - Bitget
$Liminatus Pharma (LIMN.US)$ - moomoo.com
Liminatus Pharma Warrants (LIMNW) Jump 34% to $0.07 as Traders Eye Key Inflection PointMonthly Profile - dars.gov.et
Liminatus Pharma Warrants (LIMNW) Hold Flat at $0.07 as Narrow Range Defines TradingPrice Target - dars.gov.et
Liminatus Pharma Shareholders Approve Reverse Stock Split Plan - The Globe and Mail
Liminatus Pharma Warrants (LIMNW) Remain Flat at $0.06 as Key Levels ConvergeCalendar Spread Trade - dars.gov.et
Liminatus Pharma, Inc. Primary Exchange Listing has Changed to Nasdaq Capital Market from Nasdaq Global Market - marketscreener.com
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMN - TradingView
Liminatus Pharma Warrants (LIMNW) Hold Steady at $0.04 – Flat Trading Signals ConsolidationBackspread Trade - vinanet.vn
Liminatus Pharma Inc. (LIMN) Edges Higher as Stock Tests Key Resistance LevelETF Creation Redemption - dars.gov.et
LIMN|Liminatus Pharma Ord Shs Class A|Price:0.119|Chg%:+0.002 - TradingKey
Liminatus Pharma, Inc. Revenue Breakdown – NASDAQ:LIMNW - TradingView
Liminatus Pharma Faces Nasdaq Delisting Risk, Plans Reverse Split - The Globe and Mail
Liminatus Pharma, Inc. Revenue Breakdown – BOATS:LIMN - TradingView
Liminatus Pharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) Stock Price, News & Analysis - Kalkine
Samda Biolab discloses 5.1% Liminatus Pharma (LIMN) ownership position - Stock Titan
Frontier tech research, news & data - MLQ.ai
Liminatus Pharma Warrants (LIMNW) Edge Higher: A Closer Look at the $0.06 LevelEarnings Breakout Stocks - dars.gov.et
Enterprise value to EBITDA forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Liminatus Pharma (LIMN) Plunges 16.72% as Key Support Nears $0.11PCR Mean Reversion - vinanet.vn
Price to earnings forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Enterprise value to EBIT forward of Liminatus Pharma, Inc. – BOATS:LIMNW - TradingView
Liminatus Pharma (LIMN) - Moomoo
Liminatus Pharma Warrants Plunge 36%: Key Levels and Outlook for LIMNWZero Lag EMA - vinanet.vn
Curious about the most active stocks on Thursday? - ChartMill
Liminatus Pharma Inc (LIMN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):